Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic ...

Disney will launch part of the Star Wars Day May the 4th Be With You merchandise collection next week, featuring new items ...

The latest price target for Hoth Therapeutics (NASDAQ:HOTH) was reported by D. Boral Capital on March 10, 2025. The analyst firm set a price target for $5.00 expecting HOTH to rise to within 12 ...

NEW YORK, March 26, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on developing first-in-class therapies for allergic and inflammatory diseases ...

Hoth Therapeutics (HOTH) announced breakthrough preclinical findings demonstrating the efficacy of HT-KIT, a novel targeted therapy for gastrointestinal stromal tumors. The results highlight HT ...

Hoth Therapeutics (HOTH) announced “promising” findings for its novel therapeutic candidate, HT-001, a topical neurokinin 1 receptor antagonist, in the treatment of Epidermal Growth Factor ...